These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21423258)

  • 1. Treatment of acute HCV infection.
    Grebely J; Matthews GV; Dore GJ
    Nat Rev Gastroenterol Hepatol; 2011 May; 8(5):265-74. PubMed ID: 21423258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the detection and management of acute hepatitis C virus infection.
    Martinello M; Matthews GV
    Int J Drug Policy; 2015 Oct; 26(10):899-910. PubMed ID: 26254495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users.
    Lee HC; Ko NY; Lee NY; Chang CM; Ko WC
    J Formos Med Assoc; 2008 May; 107(5):404-11. PubMed ID: 18492625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
    Naggie S; Sulkowski MS
    Gastroenterology; 2012 May; 142(6):1324-1334.e3. PubMed ID: 22537439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of chronic hepatitis C in the setting of HIV co-infection.
    Michielsen P; Bottieau E
    Acta Gastroenterol Belg; 2005; 68(1):86-91. PubMed ID: 15832592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
    Dore GJ; Hellard M; Matthews GV; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White P; French R; Rawlinson W; Lloyd AR; Kaldor JM;
    Gastroenterology; 2010 Jan; 138(1):123-35.e1-2. PubMed ID: 19782085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and HCV infection among injecting drug users.
    Hagan H; Des Jarlais DC
    Mt Sinai J Med; 2000; 67(5-6):423-8. PubMed ID: 11064493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
    Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
    J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis and HIV co-infection.
    Soriano V; Vispo E; Labarga P; Medrano J; Barreiro P
    Antiviral Res; 2010 Jan; 85(1):303-15. PubMed ID: 19887087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis C viral infections in substance abusers.
    Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):55-67. PubMed ID: 15832589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
    Khalsa JH; Vocci F
    J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.